A detailed history of Kampmann Melissa S. transactions in Dexcom Inc stock. As of the latest transaction made, Kampmann Melissa S. holds 41,240 shares of DXCM stock, worth $3.07 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares
41,240
Previous 41,285 0.11%
Holding current value
$3.07 Million
Previous $4.68 Billion 40.94%
% of portfolio
1.95%
Previous 3.42%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$64.0 - $116.06 $2,880 - $5,222
-45 Reduced 0.11%
41,240 $2.76 Billion
Q2 2024

Aug 16, 2024

SELL
$110.31 - $140.45 $45,558 - $58,005
-413 Reduced 0.99%
41,285 $4.68 Billion
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $403,539 - $494,973
3,533 Added 9.26%
41,698 $5.78 Billion
Q4 2023

Feb 22, 2024

BUY
$75.49 - $124.16 $18,117 - $29,798
240 Added 0.63%
38,165 $4.74 Billion
Q3 2023

Nov 20, 2023

BUY
$86.06 - $137.93 $3.26 Million - $5.23 Million
37,925 New
37,925 $3.54 Billion

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Kampmann Melissa S. Portfolio

Follow Kampmann Melissa S. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kampmann Melissa S., based on Form 13F filings with the SEC.

News

Stay updated on Kampmann Melissa S. with notifications on news.